期刊文献+

组蛋白密码与胶质母细胞瘤关系的研究进展

Research progress on relationship between histone code and glioblastoma
下载PDF
导出
摘要 组蛋白密码由组蛋白中被修饰氨基酸的种类、位置和修饰类型构成。目前研究发现组蛋白密码与胶质母细胞瘤(glioblastoma,GBM)密切相关。GBM细胞中各种效应蛋白与组蛋白修饰后相应靶位点的结合效应控制着染色质的状态,进一步影响GBM细胞DNA复制及基因表达调控等表观遗传现象。GBM组蛋白密码信息存在于包括组蛋白乙酰化、甲基化、磷酸化、泛素化等翻译修饰过程中。组蛋白密码与GBM关系的研究为GBM的发生发展、临床诊断和治疗研究提供了更多分子靶点。 Histone codes are characterized by the type, location, and modification of amino acids in proteins. Recent research has shown that histone codes are closely related to glioblastoma(GBM). In GBM cells, the combined effects of various effector proteins and histone-modified target sites control the state of chromatins, which further affects the epigenetic phenomena, including GBM cell DNA replication and gene expression and regulation. GBM histone code information exists in histone acetylation, methylation, phosphorylation, ubiquitination, and other post-translational modification processes. Briefly, this study on the relationship between histone code and GBM provides further molecular targets to develop the clinical diagnosis and treatment of GBM.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2015年第5期317-320,共4页 Chinese Journal of Clinical Oncology
关键词 胶质母细胞瘤 组蛋白密码 组蛋白修饰 表观遗传学 glioblastoma histone code histone modification Epigenetics
  • 相关文献

参考文献2

二级参考文献18

  • 1Guangjin Pan,James A Thomson.Nanog and transcriptional networks in embryonic stem cell pluripotency[J].Cell Research,2007,17(1):42-49. 被引量:52
  • 2LIU S. Epigenetices advancing personalized nanomedicine in can- cer therapy[J]. Adv Drug Deliv Rev, 2012, 64(13):1532-1543.
  • 3Kroep JR. Advance in epithelial ovarian cancer therapy[J]. Curr Pharm Des, 2012, 18(25) :3735--3740.
  • 4Hagelkruys A, Sawicka A, Selser C, et al. The biology of HDAC in cancer; the nuclear and epigenetic components[J]. Handb Exp Pharmacol, 2011, 206:13--37.
  • 5Kubo M, Kanaya N, Petrossian K, et ai. Inhibition of the prolifera- tion of acquired aromatase inhibitor--resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)[J]. Breast Can- cer Res Treat, 2013, 137(1):93-107.
  • 6Abaza MS, Bahman AM, AI-Atfiyah RJ, et al. Synergistic induc- tion of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome in_hibitors: potential mechanisms of action[J]. Turnout Biol, 2012, 33 (6):1951--1972.
  • 7Bai LY, Omar HA, Chiu CF, et al. Andtumor effects of (S)-HDAC42, a phenylbutyrate--derived histone deacetylase inhibitor, in multiple myeloma cells[J]. Cancer Chemother Pharmacol, 2011,68(2):489-496.
  • 8Chen MY, Liao WS, Lu Z, et al. Decitabine and suberoylanilide hy- droxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor sup- pressor genes, apoptosis, G2/M arrest, and autophagy[J]. Cancer, 2011, 117(19):4424-4438.
  • 9Dietrich CS 3rd, Greenberg VL, DeSimone CP, et al. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel--induced apoptosis in ovarian cancer cell lines[J]. Gynecol Oncol, 2010, 116(1):126-130.
  • 10Cooper AL, Greenberg VL, Lancaster PS, et al. In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hy- droxamic acid (SAHA) and paclitaxel in ovarian cancer[J]. Gynecol Oncol, 2007, 104(3) :596-601.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部